A study has found that cannabinoids from the cannabis plant may be able to help slow or stop the progression of Alzheimer’s disease.
The study, published in The American Journal of Clinical Nutrition, examined the effects of two cannabinoids, cannabidiol (CBD) and tetrahydrocannabinol (THC), on rats.
THC, which is produced by the cannabis plants, is thought to be an anti-inflammatory, while CBD is believed to slow or halt the progression and progression of the disease.
It is believed that cannabinoids are involved in brain cell growth, and may even help control the progression.
The results from the study showed that the two cannabinoids helped reduce the progression in mice of Alzheimer, while inhibiting the effects on the brain cells in the brains of mice with a known Alzheimer’s diagnosis.
THC also had a calming effect on the animals, with a reduction in locomotor activity and the animal showed signs of mild cognitive impairment.
This could be because the cannabinoids were acting on different brain areas.
However, the study was small, and it did not address whether the cannabinoids affected the progression or the effects.
The new study is just one of many that has examined the benefits of cannabinoids for Alzheimer’s.
There is evidence that cannabinoids can slow or prevent the progression, and that they can also have therapeutic potential.
It also has been shown that the cannabinoid system can be triggered by a variety of chemicals, including those that are produced naturally in the body.
This is the first study to show that cannabinoids have some of the same effects as drugs that target certain genes, but have not been specifically studied in this way.
These drugs have been shown to slow the progression on the drugs in the study.
“We’re working with pharmaceutical companies, but also some of our scientists are doing some of this research themselves, looking at the molecular biology of the cannabinoid receptors.” “
The study found that THC blocked the brain’s response to the drug in mice, but not the other drugs. “
We’re working with pharmaceutical companies, but also some of our scientists are doing some of this research themselves, looking at the molecular biology of the cannabinoid receptors.”
The study found that THC blocked the brain’s response to the drug in mice, but not the other drugs.
Dr Shire said: There’s also a possibility that CBD might help the brain by reducing the progression but this has not been shown yet.
CBD is a compound that is a component of cannabis.
This study looked at the effect of two cannabinoid compounds, cannabilisole (cannabidivarin) and cannabigerol, on brain cell activity in the hippocampus of mice.
This work is important because it will help to establish how CBD might be used in the treatment of Alzheimer disease.
CBD also has a calming action on the animal.
CBD was also found to increase locomotor behavior in the animals that were being given the drugs, and decreased the effect on their brains.
Dr Dr Shierer said: We’re using this data to explore how CBD affects the brains cells.
“It’s really important to find out whether CBD can be used for Alzheimer patients, because the effects are similar.”
This work was funded by the European Research Council, the National Institutes of Health, and the National Science Foundation.
The full study, entitled Cannabinoid CB1 Receptors, Hippocampal CB2 Receptor and Cannabinoids, are available on the Journal of Alzheimer and Dementia.
Follow @BBCNewsMagazine on Twitter and on Facebook